Medical and pre-marketing activities

ExCEEd Orphan provides medical education to all the relevant stakeholders in the field of rare diseases (including KOLs, HCPs, regulators, payers and patient advocacy groups) through the delivery of accurate, complete and unbiased information in accordance with all applicable government and industry policies. Our medical experts play a strategic role in early market access activities, developing KOL engagement strategies to gain early advocacy through the organization of peer–to-peer discussions, scientific communication, Advisory Board meetings, as well as supporting potential clinical trials. We provide validated KOLs and treatment centers mapping and segmentation, as well as a relevant product positioning plan to ensure an optimal product launch for our clients.